Sun Pharma Shares Surge 3% After Earnings Beat
By Rediff Money Desk, NEWDELHI Jan 31, 2024 16:44
Sun Pharma shares climbed over 3% on Wednesday after the company reported a strong December quarter with a 16.52% rise in net profit. The company's market cap also jumped significantly.
New Delhi, Jan 31 (PTI) Shares of Sun Pharmaceutical Industries Ltd on Wednesday climbed more than 3 per cent after the company reported a 16.52 per cent rise in its consolidated net profit to Rs 2,523.8 crore in the December quarter.
The stock gained 3.42 per cent to settle at Rs 1,418.50 apiece on the BSE. During the day, it jumped 4.87 per cent to Rs 1,438.50 -- its 52-week high.
On the NSE, it climbed 3.15 per cent to Rs 1,415 per share.
The company's market valuation rose by Rs 11,244.91 crore to Rs 3,40,337.69 crore.
The company had posted a consolidated net profit of Rs 2,166 crore in the year-ago period, Sun Pharmaceutical Industries said in a statement.
Consolidated total revenue from operations during the quarter under review stood at Rs 12,380.7 crore as compared to Rs 11,240.97 crore in the corresponding period a year ago, it added.
Total expenses were higher at Rs 9,560.74 crore as against Rs 8,943.38 crore in the same quarter of FY23.
The company's board has declared an interim dividend of Rs 8.50 per share for the year FY24 against Rs 7.50 per share interim dividend for the previous year, the statement said.
The stock gained 3.42 per cent to settle at Rs 1,418.50 apiece on the BSE. During the day, it jumped 4.87 per cent to Rs 1,438.50 -- its 52-week high.
On the NSE, it climbed 3.15 per cent to Rs 1,415 per share.
The company's market valuation rose by Rs 11,244.91 crore to Rs 3,40,337.69 crore.
The company had posted a consolidated net profit of Rs 2,166 crore in the year-ago period, Sun Pharmaceutical Industries said in a statement.
Consolidated total revenue from operations during the quarter under review stood at Rs 12,380.7 crore as compared to Rs 11,240.97 crore in the corresponding period a year ago, it added.
Total expenses were higher at Rs 9,560.74 crore as against Rs 8,943.38 crore in the same quarter of FY23.
The company's board has declared an interim dividend of Rs 8.50 per share for the year FY24 against Rs 7.50 per share interim dividend for the previous year, the statement said.
Read More On:
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 7.99 (+ 1.52)
- 58018780
- Mishtann Foods L
- 9.17 ( -5.17)
- 27555831
- Shree Securities
- 0.42 ( -6.67)
- 27309223
- AvanceTechnologies
- 0.90 ( -4.26)
- 25537567
- Rajnish Wellness
- 1.69 ( -2.87)
- 19267607
MORE NEWS
Akasa Air Pilot Concerns: Safety Issues Alleged
Akasa Air faces allegations of training and safety issues from a section of its pilots...
Pune Property Registrations Down 11% in...
Pune property registrations fell 11% year-on-year in November, despite strong demand,...
Maxivision Eye Hospitals Expands in Gujarat,...
Maxivision Super Specialty Eye Hospitals is expanding its presence in Gujarat with a Rs...